New York Life Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Buy |
84,425
+31,327
| +59% | +$864K | 0.02% | 503 |
|
|
2025
Q1 | $1.51M | Buy |
53,098
+81
| +0.2% | +$2.3K | 0.02% | 583 |
|
|
2024
Q4 | $2.2M | Buy |
53,017
+6,609
| +14% | +$275K | 0.02% | 533 |
|
|
2024
Q3 | $3.1M | Sell |
46,408
-108
| -0.2% | -$7.22K | 0.03% | 466 |
|
|
2024
Q2 | $5.52M | Buy |
46,516
+313
| +0.7% | +$37.2K | 0.06% | 310 |
|
|
2024
Q1 | $4.92M | Sell |
46,203
-1,906
| -4% | -$203K | 0.05% | 343 |
|
|
2023
Q4 | $4.78M | Buy |
48,109
+67
| +0.1% | +$6.66K | 0.05% | 337 |
|
|
2023
Q3 | $4.96M | Buy |
48,042
+639
| +1% | +$66K | 0.05% | 309 |
|
|
2023
Q2 | $5.76M | Buy |
47,403
+173
| +0.4% | +$21K | 0.06% | 287 |
|
|
2023
Q1 | $7.25M | Buy |
47,230
+253
| +0.5% | +$38.9K | 0.08% | 252 |
|
|
2022
Q4 | $8.44M | Sell |
46,977
-832
| -2% | -$149K | 0.1% | 223 |
|
|
2022
Q3 | $5.65M | Sell |
47,809
-1,213
| -2% | -$143K | 0.07% | 281 |
|
|
2022
Q2 | $7M | Buy |
+49,022
| New | +$7M | 0.08% | 253 |
|